Grifols reported EUR2.21B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alaunos Therapeutics USD 6M 1000K Jun/2026
Arca Biopharma USD 2.43B 963M Mar/2026
aTyr Pharma USD 359M 351M Nov/2026
Bio Path USD 1000K 0 Mar/2026
Brainstorm Cell Therapeutics USD 11M 3M Mar/2026
Capricor Therapeutics USD 1.66B 1.33B Dec/2025
Cara Therapeutics USD 30M 336M Mar/2026
GlaxoSmithKline GBP 74.11B 6.03B Sep/2026
Immunic USD 64M 23M Dec/2025
Nektar Therapeutics USD 2.12B 1.26B Mar/2026